Glenn Goddard's Net Worth
$18.2 Million
Who is Glenn Goddard?
Glenn Goddard has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, and Intellia Therapeutics, Inc..
SEC CIK
Glenn Goddard's CIK is 0001581992
Past Insider Trading and Trends
2014 was Glenn Goddard's most active year for acquiring shares with 30 total transactions. Glenn Goddard's most active month to acquire stocks was the month of February. 2014 was Glenn Goddard's most active year for disposing of shares, totalling 39 transactions. Glenn Goddard's most active month to dispose stocks was the month of July. 2021 saw Glenn Goddard paying a total of $1,005,745.83 for 139,232 shares, this is the most they've acquired in one year. In 2021 Glenn Goddard cashed out on 106,964 shares for a total of $8,431,771.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $43.28
Senior Vice President, FinanceGlenn Goddard used to own units in Common Stock but no longer holds any shares there.acquired a total of 147,356 shares in AGIOS PHARMACEUTICALS INC at a cost of $1,201,957.63, Glenn also disposed a total of 147,356 shares of AGIOS PHARMACEUTICALS INC equalling to $10,288,351.81.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$55.19 | -$947,469.84 |
0
|
Scheduled
|
Sep 24
| ||
Form 4
|
—
|
0
|
$75.24 | -$632,934.26 |
0
|
Scheduled
|
Jul 23
| ||
Form 4
|
—
|
0
|
$59.80 | -$1,401,626.69 |
0
|
Scheduled
|
Jul 17
| ||
Form 4
|
—
|
0
|
$71.58 | -$210,478.45 |
0
|
Scheduled
|
May 27
| ||
Form 4
|
—
|
0
|
$66.75 | -$789,775.83 |
0
|
Scheduled
|
Mar 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
$71.71 | -$127,928.36 |
0
|
Scheduled
|
Feb 13
| ||
Form 4
|
—
|
0
|
$64.65 | -$1,402,734.43 |
0
|
Scheduled
|
Feb 9 - Feb 11
| ||
Form 4
|
—
|
0
|
$44.90 | -$147,226.65 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$34.56 | -$76,530.00 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$30.87 | -$898,053.04 |
0
|
Scheduled
|
Sep 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
|
—
|
0
|
$24.28 | -$440,351.89 |
0
|
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$23.82 | -$158,926.75 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$21.83 | -$82,248.37 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$23.17 | -$88,024.73 |
0
|
Scheduled
|
Apr 4 - Apr 7
| ||
Form 4
|
—
|
0
|
$19.36 | -$149,778.34 |
0
|
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$21.31 | -$726,852.95 |
0
|
Scheduled
|
Mar 5 - Mar 7
| ||
Form 4
|
—
|
0
|
$17.77 | -$122,180.71 |
0
|
Scheduled
|
Feb 18
| ||
Form 4
|
—
|
0
|
$15.46 | -$179,835.00 |
0
|
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
$13.38 | -$180,778.50 |
0
|
Scheduled
|
Jan 27
| ||
Form 4
|
—
|
0
|
$17.59 | -$342,433.00 |
0
|
Scheduled
|
Jan 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
EVP, Chief Financial OfficerGlenn Goddard owns 69,213 units of Common Stock which is worth $1,366,956.75. From 2018 to 2024 Glenn Goddard acquired a total of 131,500 shares in Intellia Therapeutics, Inc. at a cost of $1,005,745.83, Glenn also disposed a total of 62,287 shares of Intellia Therapeutics, Inc. equalling to $8,793,832.17.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +70.54% | 28.63K |
—
|
—
| 69.21K |
Mar 1
| |||
Form 4
| -11.68% | -5.37K |
$29.46 | -$158,052.90 | 40.59K |
Jan 3
| |||
Form 4
| +7.14% | 3.06K |
—
|
—
| 45.95K |
Jan 1
| |||
Form 4
| +178.42% | 27.48K |
—
|
—
| 42.89K |
Mar 1
| |||
Form 4
| -13.61% | -2.43K |
$37.21 | -$90,308.67 | 15.4K |
Jan 4
| |||
Form 4
| +20.73% | 3.06K |
—
|
—
| 17.83K |
Jan 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 14.77K |
$112.24 | -$113,699.12 | 14.77K |
Jan 1 - Mar 1
| |||
Form 4
|
—
|
0
|
$97.35 | -$576,410.28 |
0
|
Scheduled
|
Sep 7
| ||
Form 4
|
—
|
0
|
$89.22 | -$4,213,959.29 |
0
|
Scheduled
|
Aug 30 - Aug 31
| ||
Form 4
|
—
|
0
|
$85.16 | -$2,635,656.08 |
0
|
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||